Regulation of insulin and glucagon secretion from rat pancreatic islets in vitro by somatostatin analogues

Regulatory Peptides

Volumn 138, Issue 1, 2007, Pages 1-9

  Ludvigsen, E ^a   Stridsberg, M ^a   Taylor, J E ^b   Culler, M D ^b   Oberg K ^a   Janson, E T ^a   Sandler, S ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b Biomeasure Inc   (United States)

Author keywords

Glucagon secretion; Insulin secretion; Pancreatic islets; Somatostatin analogues; Somatostatin receptors

Indexed keywords

BIM 23120; BIM 23206; BIM 23926; GLUCAGON; INSULIN; OCTREOTIDE; PASIREOTIDE; SOMATOSTATIN 14; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR 1; SOMATOSTATIN RECEPTOR 2; SOMATOSTATIN RECEPTOR 5;

ANIMAL CELL; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; GLUCAGON RELEASE; IN VITRO STUDY; INHIBITION KINETICS; INSULIN RELEASE; LONG TERM EXPOSURE; MALE; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; GASTROINTESTINAL AGENTS; GLUCAGON; INSULIN; ISLETS OF LANGERHANS; MALE; OCTREOTIDE; RATS; RATS, SPRAGUE-DAWLEY; SOMATOSTATIN;

EID: 33845480306     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2006.07.006     Document Type: Article

References (24)

1. Brazeau P., Vale W., Burgus R., Ling N., Butcher M., Rivier J., and Guillemin R. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 68 (1973) 77-79
2. Moller L.N., Stidsen C.E., Hartmann B., and Holst J.J. Somatostatin receptors. Biochim Biophys Acta 1 (2003) 1-84
3. Patel Y.C. Somatostatin and its receptor family. Front Neuroendocrinol 3 (1999) 157-198
4. Bauer W., Briner U., Doepfner W., Haller R., Huguenin R., Marbach P., Petcher T.J., and Pless. SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci 11 (1982) 1133-1140
5. Janson E.T., and Oberg K. Somatostatin receptor ligands and their use in the treatment of endocrine disorders. Curr Pharm Des 9 (1999) 693-705
6. Bruns C., Lewis I., Briner U., Meno-Tetang G., and Weckbecker G. SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile. Eur J Endocrinol 5 (2002) 707-716
7. Cattaneo M.G., Taylor J.E., Culler M.D., Nisoli E., and Vicentini L.M. Selective stimulation of somatostatin receptor subtypes: differential effects on Ras/MAP kinase pathway and cell proliferation in human neuroblastoma cells. FEBS Lett 3 (2000) 271-276
8. Ludvigsen E., Stridsberg M., Taylor J.E., Culler M.D., Oberg K., and Janson E.T. Subtype selective interactions of somatostatin and somatostatin analogs with sst(1), sst(2), and sst(5) in BON-1 cells. Med Oncol 3 (2004) 285-295
9. Zatelli M.C., Tagliati F., Taylor J.E., Rossi R., Culler M.D., and Degli Uberti E.C. Somatostatin receptor subtypes 2 and 5 differentially affect proliferation in vitro of the human medullary thyroid carcinoma cell line tt. J Clin Endocrinol Metab 5 (2001) 2161-2169
10. Zatelli M.C., Tagliati F., Taylor J.E., Piccin D., Culler M.D., and Degli Uberti E.C. Somatostatin, but not somatostatin receptor subtypes 2 and 5 selective agonists, inhibits calcitonin secretion and gene expression in the human medullary thyroid carcinoma cell line, TT. Horm Metab Res 5 (2002) 229-233
11. Kumar U., Sasi R., Suresh S., Patel A., Thangaraju M., Metrakos P., Patel S.C., and Patel Y.C. Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis. Diabetes 1 (1999) 77-85
12. Ludvigsen E., Olsson R., Stridsberg M., Janson E.T., and Sandler S. Expression and distribution of somatostatin receptor subtypes in the pancreatic islets of mice and rats. J Histochem Cytochem 3 (2004) 391-400
13. Portela-Gomes G.M., Stridsberg M., Grimelius L., Oberg K., and Janson E.T. Expression of the five different somatostatin receptor subtypes in endocrine cells of the pancreas. Appl Immunohistochem Mol Morphol 2 (2000) 126-132
14. Strowski M.Z., Parmar R.M., Blake A.D., and Schaeffer J.M. Somatostatin inhibits insulin and glucagon secretion via two receptor subtypes: an in vitro study of pancreatic islets from somatostatin receptor 2 knockout mice. Endocrinology 1 (2000) 111-117
15. Strowski M.Z., Kohler M., Chen H.Y., Trumbauer M.E., Li Z.H., Szalkowski D., Gopal-Truter S., Fisher J.K., Schaeffer J.M., Blake A.D., Zhang B.B., and Wilkinson H.A. Somatostatin receptor subtype 5 regulates insulin secretion and glucose homeostasis. Mol Endocrinol 1 (2003) 93-106
16. Cejvan K., Coy D.H., and Efendic S. Intra-islet somatostatin regulates glucagon release via type 2 somatostatin receptors in rats. Diabetes 5 (2003) 1176-1181
17. Fagan S.P., Azizzadeh A., Moldovan S., Ray M.K., Adrian T.E., Ding X., Coy D.H., and Brunicardi F.C. Insulin secretion is inhibited by subtype five somatostatin receptor in the mouse. Surgery 2 (1998) 254-258
18. Sandler S., Andersson A., and Hellerstrom C. Inhibitory effects of interleukin 1 on insulin secretion, insulin biosynthesis, and oxidative metabolism of isolated rat pancreatic islets. Endocrinology 4 (1987) 1424-1431
19. Shimon I., Taylor J.E., Dong J.Z., Bitonte R.A., Kim S., Morgan B., Coy D.H., Culler M.D., and Melmed S. Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation. J Clin Invest 4 (1997) 789-798
20. Cardozo A.K., Kruhoffer M., Leeman R., Orntoft T., and Eizirik D.L. Identification of novel cytokine-induced genes in pancreatic beta-cells by high-density oligonucleotide arrays. Diabetes 5 (2001) 909-920
21. Ahren B., Jarhult J., and Lundquist I. Enhancement of insulin secretion during selective blockade of alpha 1- and alpha 2-adrenoceptors in the rat: effects of somatostatin. Acta Physiol Scand 2 (1982) 257-260
22. Ludvigsen E., Stridsberg M., Janson E.T., and Sandler S. Expression of somatostatin receptor subtypes 1-5 in pancreatic islets of normoglycaemic and diabetic NOD mice. Eur J Endocrinol 3 (2005) 445-454
23. Vondra K., Voborska M., Kvapil M., Weber P., Dvorakova H., Stanicka S., and Zamrazil V. Somatostatin: beneficial effects on remission in young adult patients with newly diagnosed diabetes mellitus type 1. Physiol Res 1 (2004) 115-117
24. Bruns C., Lewis I., Briner U., Meno-Tetang G., and Weckbecker G. SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile. Eur J Endocrinol 5 (2002) 707-716